de BlackRock Ionis Pharmaceuticals IONS Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 849 M | Comprar |
10,704,660
+262,184
| +3% | +USD 19.7 M | 0.01% | 862 |
|
|
2026
Q1 | USD 784 M | Vender |
10,442,476
-205,387
| -2% | -USD 16.2 M | 0.01% | 820 |
|
|
2025
Q4 | USD 842 M | Comprar |
10,647,863
+199,923
| +2% | +USD 15.1 M | 0.01% | 770 |
|
|
2025
Q3 | USD 684 M | Vender |
10,447,940
-448,997
| -4% | -USD 21.9 M | 0.01% | 883 |
|
|
2025
Q2 | USD 431 M | Vender |
10,896,937
-367,505
| -3% | -USD 12 M | 0.01% | 1156 |
|
|
2025
Q1 | USD 340 M | Vender |
11,264,442
-401,106
| -3% | -USD 13.1 M | 0.01% | 1265 |
|
|
2024
Q4 | USD 408 M | Comprar |
11,665,548
+852,525
| +8% | +USD 31.9 M | 0.01% | 1212 |
|
|
2024
Q3 | USD 433 M | Comprar |
10,813,023
+491,993
| +5% | +USD 22.9 M | 0.01% | 1181 |
|
|
2024
Q2 | USD 492 M | Comprar |
10,321,030
+549,139
| +6% | +USD 22.5 M | 0.01% | 1018 |
|
|
2024
Q1 | USD 424 M | Comprar |
9,771,891
+714,361
| +8% | +USD 34.1 M | 0.01% | 1151 |
|
|
2023
Q4 | USD 458 M | Vender |
9,057,530
-57,097
| -0.6% | -USD 2.73 M | 0.01% | 1079 |
|
|
2023
Q3 | USD 413 M | Vender |
9,114,627
-21,547
| -0.2% | -USD 889 k | 0.01% | 1034 |
|
|
2023
Q2 | USD 375 M | Comprar |
9,136,174
+153,928
| +2% | +USD 5.92 M | 0.01% | 1133 |
|
|
2023
Q1 | USD 321 M | Vender |
8,982,246
-97,311
| -1% | -USD 3.65 M | 0.01% | 1218 |
|
|
2022
Q4 | USD 343 M | Comprar |
9,079,557
+143,495
| +2% | +USD 6.04 M | 0.01% | 1151 |
|
|
2022
Q3 | USD 395 M | Comprar |
8,936,062
+104,672
| +1% | +USD 4.41 M | 0.01% | 970 |
|
|
2022
Q2 | USD 327 M | Comprar |
8,831,390
+387,547
| +5% | +USD 14.6 M | 0.01% | 1159 |
|
|
2022
Q1 | USD 313 M | Vender |
8,443,843
-95,439
| -1% | -USD 3.12 M | 0.01% | 1327 |
|
|
2021
Q4 | USD 260 M | Comprar |
8,539,282
+419,429
| +5% | +USD 13.2 M | 0.01% | 1539 |
|
|
2021
Q3 | USD 272 M | Vender |
8,119,853
-59,813
| -0.7% | -USD 2.25 M | 0.01% | 1491 |
|
|
2021
Q2 | USD 326 M | Vender |
8,179,666
-1,628,896
| -17% | -USD 63.8 M | 0.01% | 1408 |
|
|
2021
Q1 | USD 441 M | Comprar |
9,808,562
+58,060
| +0.6% | +USD 3.24 M | 0.01% | 1106 |
|
|
2020
Q4 | USD 551 M | Comprar |
9,750,502
+1,285,095
| +15% | +USD 64 M | 0.02% | 831 |
|
|
2020
Q3 | USD 402 M | Vender |
8,465,407
-185,321
| -2% | -USD 10.3 M | 0.01% | 879 |
|
|
2020
Q2 | USD 510 M | Comprar |
8,650,728
+482,788
| +6% | +USD 26.9 M | 0.02% | 699 |
|
|
2020
Q1 | USD 386 M | Vender |
8,167,940
-234,449
| -3% | -USD 13.1 M | 0.02% | 752 |
|
|
2019
Q4 | USD 508 M | Comprar |
8,402,389
+51,590
| +0.6% | +USD 3.07 M | 0.02% | 797 |
|
|
2019
Q3 | USD 500 M | Vender |
8,350,799
-451,777
| -5% | -USD 29.4 M | 0.02% | 751 |
|
|
2019
Q2 | USD 566 M | Comprar |
8,802,576
+1,181,004
| +15% | +USD 83.5 M | 0.02% | 676 |
|
|
2019
Q1 | USD 619 M | Vender |
7,621,572
-54,685
| -0.7% | -USD 3.53 M | 0.03% | 617 |
|
|
2018
Q4 | USD 415 M | Comprar |
7,676,257
+213,000
| +3% | +USD 10.9 M | 0.02% | 752 |
|
|
2018
Q3 | USD 385 M | Comprar |
7,463,257
+408,678
| +6% | +USD 19.2 M | 0.02% | 957 |
|
|
2018
Q2 | USD 294 M | Comprar |
7,054,579
+124,233
| +2% | +USD 5.51 M | 0.01% | 1128 |
|
|
2018
Q1 | USD 305 M | Vender |
6,930,346
-42,260
| -0.6% | -USD 2.15 M | 0.01% | 1060 |
|
|
2017
Q4 | USD 351 M | Vender |
6,972,606
-30,885
| -0.4% | -USD 1.69 M | 0.02% | 948 |
|
|
2017
Q3 | USD 355 M | Comprar |
7,003,491
+179,504
| +3% | +USD 9.4 M | 0.02% | 890 |
|
|
2017
Q2 | USD 347 M | Comprar |
6,823,987
+264,179
| +4% | +USD 12.3 M | 0.02% | 869 |
|
|
2017
Q1 | USD 264 M | Comprar |
6,559,808
+6,542,394
| +37,570% | +USD 294 M | 0.01% | 1066 |
|
|
2016
Q4 | USD 833 k | Vender |
17,414
-1,541
| -8% | -USD 61 k | ﹤0.01% | 1552 |
|
|
2016
Q3 | USD 695 k | Vender |
18,955
-82,238
| -81% | -USD 2.57 M | ﹤0.01% | 1626 |
|
|
2016
Q2 | USD 2.36 M | Vender |
101,193
-75,463
| -43% | -USD 2.43 M | ﹤0.01% | 1095 |
|
|
2016
Q1 | USD 7.16 M | Vender |
176,656
-10,553
| -6% | -USD 429 k | 0.01% | 770 |
|
|
2015
Q4 | USD 11.6 M | Comprar |
187,209
+63,388
| +51% | +USD 3.42 M | 0.02% | 646 |
|
|
2015
Q3 | USD 5 M | Vender |
123,821
-34,154
| -22% | -USD 1.77 M | 0.01% | 784 |
|
|
2015
Q2 | USD 9.09 M | Vender |
157,975
-113,103
| -42% | -USD 7.19 M | 0.01% | 691 |
|
|
2015
Q1 | USD 17.3 M | Comprar |
271,078
+114,013
| +73% | +USD 7.74 M | 0.02% | 557 |
|
|
2014
Q4 | USD 9.7 M | Comprar |
157,065
+153,700
| +4,568% | +USD 7.58 M | 0.01% | 682 |
|
|
2014
Q3 | USD 130 k | Vender |
3,365
-1,570
| -32% | -USD 55.6 k | ﹤0.01% | 1639 |
|
|
2014
Q2 | USD 170 k | Vender |
4,935
-78,545
| -94% | -USD 2.47 M | ﹤0.01% | 1575 |
|
|
2014
Q1 | USD 3.61 M | Vender |
83,480
-37,444
| -31% | -USD 1.82 M | 0.01% | 912 |
|
|
2013
Q4 | USD 4.82 M | Comprar |
120,924
+117,387
| +3,319% | +USD 4.18 M | 0.01% | 841 |
|
|
2013
Q3 | USD 133 k | Mantener |
3,537
| – | – | ﹤0.01% | 1594 |
|
|
2013
Q2 | USD 95 k | Comprar |
+3,537
| Nuevas | +USD 75.2 k | ﹤0.01% | 1677 |
|
Otros fondos que tienen IONS en su cartera
Posición de BlackRock en IONS: resumen de T2 2026
BlackRock aumentó su participación en Ionis Pharmaceuticals (IONS) en 2.5% durante T2 2026, al comprar aproximadamente USD 19.7 M y elevar la posición a 10,704,660 acciones con un valor de USD 849 M. La posición representa 0.01% de la cartera y ocupa el puesto #862.
BlackRock reportó por primera vez una posición en IONS en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 516 fondos que sigue Wall St. Rank mantienen una posición en IONS.
- Al cierre de T2 2026, BlackRock tenía 10,704,660 acciones de Ionis Pharmaceuticals con un valor de USD 849 M.
- BlackRock compró 262,184 acciones de Ionis Pharmaceuticals en T2 2026, por un monto estimado de USD 19.7 M.
- Ionis Pharmaceuticals representó 0.01% de la cartera de BlackRock en T2 2026 y fue su posición número 862.
- BlackRock reportó por primera vez una posición en Ionis Pharmaceuticals en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 516 fondos que sigue Wall St. Rank tenían Ionis Pharmaceuticals en cartera.
Según el Informe 13F de BlackRock correspondiente a T2 2026, presentado el 7 ago 2026.